Eli Lilly’s weight problems drug retatrutide passes late-stage diabetes trial
Eli Lilly's logo appears at the company's office in San Diego, California, USA on November 21, 2025.Mike Blake | ReutersEli Lilly announced Thursday that its next-generation obesity drug, retatrutide, has passed its first late-stage…